Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018;40(6):569-573.
doi: 10.1080/10641963.2017.1411493. Epub 2017 Dec 6.

Pharmacist-based antihypertensive medication review and assignment of morning versus evening dosing of once-daily antihypertensive medications: A pilot study to assess feasibility and efficacy in chronic kidney disease patients

Julia R Smith  1 , Lisa Hillman  1 , Paul E Drawz  2
Affiliations
Randomized Controlled Trial

Pharmacist-based antihypertensive medication review and assignment of morning versus evening dosing of once-daily antihypertensive medications: A pilot study to assess feasibility and efficacy in chronic kidney disease patients

Julia R Smith et al. Clin Exp Hypertens. 2018.

Abstract

Evening dosing of antihypertensive medications lowers nighttime blood pressure, and in one large randomized trial, it reduced the risk for cardiovascular outcomes. However, the feasibility of nighttime dosing in routine clinical practice is unknown. The purpose of this pilot study was to evaluate the effect of a brief pharmacist intervention to assign patients to take antihypertensive medications at specific times of the day. In this pilot, randomized controlled trial, 79 patients with moderate to severe chronic kidney disease (CKD) taking one or more antihypertensive medications once daily were randomized to take one once-daily antihypertensive either in the morning or in the evening. A total of 79 patients were randomized (39 to morning dosing, 40 to evening dosing). Average (SD) age was 56.5 (14) years, 68% were male, and average (SD) estimated glomerular filtration rate (eGFR) was 36.6 (8.9) mL/min/1.73m2. Adherence, defined as taking the once-daily medication at the time indicated six or seven times in the last 7 days and not taking it at any other time during the day, was 91% in the morning arm and 95% in the evening arm (p = 0.57). This pilot demonstrates the feasibility and efficacy of a pharmacist-physician collaborative to assign once-daily antihypertensive medications to either morning or evening dosing.

Keywords: Hypertension; adherence; chronic kidney disease; chronotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interests, financial or otherwise, to disclose.

Figures

Figure 1:
Figure 1:
CONSORT: Trial Process Flow
See this image and copyright information in PMC

References

    1. James PA, Oparil S, Carter BL, et al. 2014. evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA February 05 2014;311(5):507–520. - PubMed
    1. Mehta R, Drawz PE. Is nocturnal blood pressure reduction the secret to reducing the rate of progression of hypertensive chronic kidney disease? Curr Hypertens Rep October 2011;13(5):378–385. - PMC - PubMed
    1. Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA. Predictive role of the nighttime blood pressure. Hypertension January 2011;57(1):3–10. - PubMed
    1. Minutolo R, Gabbai FB, Borrelli S, et al. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Am J Kidney Dis December 2007;50(6):908–917. - PubMed
    1. Drawz PE, Rosenthal N, Babineau DC, Rahman M. Nighttime hospital blood pressure--a predictor of death, ESRD, and decline in GFR. Ren Fail 2010;32(9):1036–1043. - PMC - PubMed

Publication types

Substances